Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
manilatimes4h
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...
Impacts5h
AI-Powered PowerPoint Presentations: Revolutionizing the Way We Create and Deliver Presentations
In today’s fast-paced digital world, creating engaging and professional presentations has become more crucial than ever. The ...
manilatimes5h
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...
Moneylife11h
Budget 2025: What Lies Beneath Tax Data and the State of MSMEs
Tax and fiscal practitioners who have observed the annual budget presentations over half a century recognise the fact that the euphoria emanating from the event evaporates into ether in a matter of ...